EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Soluble CD137: A Potential Prognostic Biomarker in Critically Ill Patients

Ulrich Räth, Patricia Mester, Herbert Schwarz iD, Stephan Schmid iD, Martina Müller, Christa Buechler iD, Vlad Pavel iD

International Journal of Molecular Sciences · 15.12.2023 · 24 (24) · 17518

DOI: 10.3390/ijms242417518 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 15.12.2023. Verfasst von Ulrich Räth und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, and Infectious Diseases, University Hospital Regensburg…. Hauptthemen laut MEDLINE: Critical Illness, Sepsis, Tumor Necrosis Factor Receptor Superfamily, Member 9. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

T cell depletion and functional impairment are characteristics of sepsis. CD137 is a costimulatory receptor on activated T cells, while soluble CD137 (sCD137) inhibits CD137 signaling. This study found elevated sCD137 levels in the plasma of patients with systemic inflammatory response syndrome (SIRS), sepsis, or septic shock compared to healthy controls. The sCD137 levels negatively correlated with the C-reactive protein and positively with procalcitonin and interleukin-6. There was no difference in sCD137 levels based on ventilation, dialysis, or vasopressor treatment. Patients with SARS-CoV-2, Gram-positive, or Gram-negative bacterial infections had similar sCD137 levels as noninfected individuals. Notably, higher plasma sCD137 levels were observed in non-survivors compared to survivors in both the SIRS/sepsis group and the SARS-CoV-2 subgroup. In conclusion, plasma sCD137 levels are associated with severe illness and survival in critically ill patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Critical IllnessSepsisTumor Necrosis Factor Receptor Superfamily, Member 9HumansBiomarkersPrognosisReceptors, Tumor Necrosis FactorRenal DialysisSystemic Inflammatory Response Syndrome

Stichwörter der Autor:innen

COVID-19bacterial infectionsCD137sepsissurvival

Substanzen

BiomarkersReceptors, Tumor Necrosis FactorTumor Necrosis Factor Receptor Superfamily, Member 9

Autor:innen und Institutionen

  • Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, and Infectious Diseases, University Hospital Regensburg, 93053 Regensburg, Germany.
  • Department of Physiology, and Immunology Programme, Yong Loo Lin School of Medicine, National University of Singapore, MD9, Singapore 117597, Singapore.

ORCID-Profile: Herbert Schwarz, Stephan Schmid, Christa Buechler, Vlad Pavel

Zitieren

APA

Räth, U., Mester, P., Schwarz, H., Schmid, S., Müller, M., Buechler, C., & Pavel, V. (2023). Soluble CD137: A Potential Prognostic Biomarker in Critically Ill Patients. International Journal of Molecular Sciences, 24(24), 17518. https://doi.org/10.3390/ijms242417518

Vancouver

Räth U, Mester P, Schwarz H, Schmid S, Müller M, Buechler C, et al. Soluble CD137: A Potential Prognostic Biomarker in Critically Ill Patients. International Journal of Molecular Sciences. 2023;24(24):17518. doi:10.3390/ijms242417518

BibTeX
@article{Rth2023,
  author = {Räth, Ulrich and Mester, Patricia and Schwarz, Herbert and Schmid, Stephan and Müller, Martina and Buechler, Christa and Pavel, Vlad},
  title = {Soluble CD137: A Potential Prognostic Biomarker in Critically Ill Patients},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {24},
  pages = {17518},
  doi = {10.3390/ijms242417518}
}
Kostenlos starten →